Cora Peterson1, Likang Xu2, Curtis Florence2, Sharyn E Parks2, Ted R Miller3, Ronald G Barr4, Marilyn Barr5, Ryan Steinbeigle5. 1. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia; cora.peterson@cdc.hhs.gov. 2. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia; 3. Pacific Institute for Research & Evaluation, Calverton, Maryland, and Centre for Population Health Research, Curtin University, Perth, Australia; 4. Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada; and. 5. National Center on Shaken Baby Syndrome, Farmington, Utah.
Abstract
OBJECTIVES: Health consequences of shaken baby syndrome, or pediatric abusive head trauma (AHT), can be severe and long-lasting. We aimed to estimate the multiyear medical cost attributable to AHT. METHODS: Using Truven Health MarketScan data, 2003-2011, we identified children 0 to 4 years old with commercial or Medicaid insurance and AHT diagnoses. We used exact case-control matching based on demographic and insurance characteristics such as age and health plan type to compare medical care between patients with and without AHT diagnoses. Using regression models, we assessed service use (ie, average annual number of inpatient visits per patient) and inpatient, outpatient (including emergency department), drug, and total medical costs attributable to an AHT diagnosis during the 4-year period after AHT diagnosis. RESULTS: We assessed 1209 patients with AHT and 5895 matched controls. Approximately 48% of patients with AHT received inpatient care within 2 days of initial diagnosis, and 25% were treated in emergency departments. AHT diagnosis was associated with significantly greater medical service use and higher inpatient, outpatient, drug, and total costs for multiple years after the diagnosis. The estimated total medical cost attributable to AHT in the 4 years after diagnosis was $47,952 (95% confidence interval [CI], $40,219-$55,685) per patient with AHT (2012 US dollars) and differed for commercially insured ($38,231 [95% CI, $29,898-$46,564]) and Medicaid ($56,691 [95% CI, $4290-$69,092]) patients. CONCLUSIONS: Children continue to have substantial excess medical costs for years after AHT. These estimates exclude related nonmedical costs such as special education and disability that also are attributable to AHT.
OBJECTIVES: Health consequences of shaken baby syndrome, or pediatric abusive head trauma (AHT), can be severe and long-lasting. We aimed to estimate the multiyear medical cost attributable to AHT. METHODS: Using Truven Health MarketScan data, 2003-2011, we identified children 0 to 4 years old with commercial or Medicaid insurance and AHT diagnoses. We used exact case-control matching based on demographic and insurance characteristics such as age and health plan type to compare medical care between patients with and without AHT diagnoses. Using regression models, we assessed service use (ie, average annual number of inpatient visits per patient) and inpatient, outpatient (including emergency department), drug, and total medical costs attributable to an AHT diagnosis during the 4-year period after AHT diagnosis. RESULTS: We assessed 1209 patients with AHT and 5895 matched controls. Approximately 48% of patients with AHT received inpatient care within 2 days of initial diagnosis, and 25% were treated in emergency departments. AHT diagnosis was associated with significantly greater medical service use and higher inpatient, outpatient, drug, and total costs for multiple years after the diagnosis. The estimated total medical cost attributable to AHT in the 4 years after diagnosis was $47,952 (95% confidence interval [CI], $40,219-$55,685) per patient with AHT (2012 US dollars) and differed for commercially insured ($38,231 [95% CI, $29,898-$46,564]) and Medicaid ($56,691 [95% CI, $4290-$69,092]) patients. CONCLUSIONS:Children continue to have substantial excess medical costs for years after AHT. These estimates exclude related nonmedical costs such as special education and disability that also are attributable to AHT.
Authors: Jeremy A Rassen; Abhi A Shelat; Jessica Myers; Robert J Glynn; Kenneth J Rothman; Sebastian Schneeweiss Journal: Pharmacoepidemiol Drug Saf Date: 2012-05 Impact factor: 2.890
Authors: Ronald G Barr; Frederick P Rivara; Marilyn Barr; Peter Cummings; James Taylor; Liliana J Lengua; Emily Meredith-Benitz Journal: Pediatrics Date: 2009-03 Impact factor: 7.124
Authors: Joanne Klevens; Brian Schmidt; Feijun Luo; Likang Xu; Katie A Ports; Rosalyn D Lee Journal: Public Health Rep Date: 2017-06-13 Impact factor: 2.792
Authors: Nikki Miller Ferguson; Ajit Sarnaik; Darryl Miles; Nadeem Shafi; Mark J Peters; Edward Truemper; Monica S Vavilala; Michael J Bell; Stephen R Wisniewski; James F Luther; Adam L Hartman; Patrick M Kochanek Journal: Crit Care Med Date: 2017-08 Impact factor: 7.598
Authors: Adam J Zolotor; Desmond K Runyan; Meghan Shanahan; Christine Piette Durrance; Maryalice Nocera; Kelly Sullivan; Joanne Klevens; Robert Murphy; Marilyn Barr; Ronald G Barr Journal: JAMA Pediatr Date: 2015-12 Impact factor: 16.193